Luke J Laffin

17PUBLICATIONS

25CO-AUTHORS

Systems physiologyCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)PharmacogenomicsChild and adolescent development

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|Jun 05, 2026

Advancing Hypertension Treatment in Obstructive Sleep Apnea.

|Apr 11, 2026

Effect of bempedoic acid in the absence of background lipid-lowering therapy on LDL cholesterol, hsCRP, and cardiovascular outcomes, among statin-intolerant patients: a post-hoc analysis of the CLEAR Outcomes trial.

Carolina P Zingano, Danielle M Brennan, LeAnne Bloedon

|Mar 19, 2026

Angiotensinogen Reconsidered: Evolving Perspectives in Hypertension Research.

Mehmet Kanbay, Mustafa Guldan, Lasin Ozbek

|Feb 09, 2026

Aldosterone synthase inhibitors for hypertension: A breakthrough facing barriers to adoption.

Luke J Laffin, Steven E Nissen

|Oct 24, 2025

In Reply: Time in Target Range, Sex-Specific Effects, and the Path to Clinical Integration.

Neel Agarwal, Julie St John, Luke J Laffin

|Jul 08, 2025

Association of Systolic Blood Pressure Time in Target Range With Cardiovascular Events Among PRECISION Participants.

Neel Agarwal, Julie St John, Vikas Sunder

Pageof 3

Frequent Collaborators

Erik H Van Iterson

Dennis Bruemmer

Steven E Nissen

Joseph Kassab

Joseph El Dahdah

Michel Chedid El Helou

Ashish Sarraju

Leslie Cho

Samir R Kapadia

Patrick Collier

Frequent Collaborators

Erik H Van Iterson

Dennis Bruemmer

Steven E Nissen

Joseph Kassab